Programs will leverage ABL Bio's Grabody-B platform technology to deliver molecules across the blood-brain barrier.

The pharma giant is wagering potentially billions of dollars on technology from ABL Bio that’s designed to get drugs across ...

The global Personalized Medicine Market is valued at USD 550.2 Billion in 2024 and is projected to reach a value of USD ...

Market OverviewThe global Vaccines Market has evolved significantly in recent years, driven by advancements in biotechnology, ...

GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.

Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting ...

Just months after it started trading on the Nasdaq in June 2021, the company was valued as high as $5.8 billion. As of Friday ...

MRS Oil Nigeria Plc has announced plans to voluntarily delist its shares from the Nigerian Exchange Limited (NGX) following a ...

The TTA summary of the bankruptcy 24-26 March This Editor likened the 23andMe implosion to that of Theranos–a watershed event that forces a rethinking of how we treat the privacy of customer medical ...

What if you could spot stocks early—before they become the talk of the market? Investors often chase fundamentally strong ...

Pre-specified interim analysis of Phase 3 PIVOT-PO clinical trial of tebipenem HBr in complicated urinary tract infection (cUTI) is expected to ...

Good evening and welcome to Dyadic International's Year-End 2024 Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, there will be a brief ...